{"url_path":"/sec/ktta/10-q/2026/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1841330/0001213900-26-057837-index.html","accession_number":"0001213900-26-057837","cik":"0001841330","ticker":"KTTA","issuer_name":"Pasithea Therapeutics Corp.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1841330/0001213900-26-057837-index.html","primary_entity_key":"0001841330","primary_entity_name":"Pasithea Therapeutics Corp."},"word_count":1216,"has_tables":true,"body_markdown":"ktta-20260331\n\nhttp://fasb.org/us-gaap/2026#SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration\nP5Y\nP3Y\nP10Y\n1\n1\n1\n1\n\nfalse\nQ1\n0001841330\n--12-31\n\n0001841330\n\n2026-01-01\n2026-03-31\n\n0001841330\n\nus-gaap:SubsequentEventMember\nus-gaap:CommonStockMember\n\n2026-04-01\n2026-05-13\n\n0001841330\n\nus-gaap:SubsequentEventMember\nktta:DecemberTwoThousandTwentyFIVEPreFundedWarrantsMember\n\n2026-05-13\n\n0001841330\n\nus-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember\n\n2025-01-01\n2025-03-31\n\n0001841330\n\nus-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember\n\n2026-01-01\n2026-03-31\n\n0001841330\n\n2025-10-01\n2025-10-01\n\n0001841330\n\n2025-09-30\n2025-09-30\n\n0001841330\n\nus-gaap:EmployeeStockOptionMember\n\n2025-01-01\n2025-03-31\n\n0001841330\n\nus-gaap:WarrantMember\n\n2025-01-01\n2025-03-31\n\n0001841330\n\nus-gaap:EmployeeStockOptionMember\n\n2026-01-01\n2026-03-31\n\n0001841330\n\nus-gaap:WarrantMember\n\n2026-01-01\n2026-03-31\n\n0001841330\n\nus-gaap:WarrantMember\n\n2026-03-31\n\n0001841330\n\nktta:ExercisePriceOneTwentyFivePointZeroZeroMember\nus-gaap:WarrantMember\n\n2026-01-01\n2026-03-31\n\n0001841330\n\nktta:ExercisePriceOneTwentyFivePointZeroZeroMember\nus-gaap:WarrantMember\n\n2026-03-31\n\n0001841330\n\nktta:ExercisePriceOneTwentyPointZeroZeroMember\nus-gaap:WarrantMember\n\n2026-01-01\n2026-03-31\n\n0001841330\n\nktta:ExercisePriceOneTwentyPointZeroZeroMember\nus-gaap:WarrantMember\n\n2026-03-31\n\n0001841330\n\nus-gaap:WarrantMember\nktta:ExercisePriceThirtySevenPointSixZeroMember\n\n2026-01-01\n2026-03-31\n\n0001841330\n\nus-gaap:WarrantMember\nktta:ExercisePriceThirtySevenPointSixZeroMember\n\n2026-03-31\n\n0001841330\n\nus-gaap:WarrantMember\nktta:ExercisePriceTwentyPointZeroZeroMember\n\n2026-01-01\n2026-03-31\n\n0001841330\n\nus-gaap:WarrantMember\nktta:ExercisePriceTwentyPointZeroZeroMember\n\n2026-03-31\n\n0001841330\n\nktta:ExercisePriceEightPointOneThreeMember\nus-gaap:WarrantMember\n\n2026-01-01\n2026-03-31\n\n0001841330\n\nktta:ExercisePriceEightPointOneThreeMember\nus-gaap:WarrantMember\n\n2026-03-31\n\n0001841330\n\nktta:ExercisePriceFivePointOneThreeMember\nus-gaap:WarrantMember\n\n2026-01-01\n2026-03-31\n\n0001841330\n\nktta:ExercisePriceFivePointOneThreeMember\nus-gaap:WarrantMember\n\n2026-03-31\n\n0001841330\n\nktta:ExercisePriceThreePointEightFiveMember\nus-gaap:WarrantMember\n\n2026-01-01\n2026-03-31\n\n0001841330\n\nktta:ExercisePriceThreePointEightFiveMember\nus-gaap:WarrantMember\n\n2026-03-31\n\n0001841330\n\nktta:ExercisePriceOnePointSevenFiveMember\nus-gaap:WarrantMember\n\n2026-01-01\n2026-03-31\n\n0001841330\n\nktta:ExercisePriceOnePointSevenFiveMember\nus-gaap:WarrantMember\n\n2026-03-31\n\n0001841330\n\nktta:ExercisePriceOnePointFourZeroMember\nus-gaap:WarrantMember\n\n2026-01-01\n2026-03-31\n\n0001841330\n\nktta:ExercisePriceOnePointFourZeroMember\nus-gaap:WarrantMember\n\n2026-03-31\n\n0001841330\n\nktta:ExercisePriceZeroPointNineFourMember\nus-gaap:WarrantMember\n\n2026-01-01\n2026-03-31\n\n0001841330\n\nktta:ExercisePriceZeroPointNineFourMember\nus-gaap:WarrantMember\n\n2026-03-31\n\n0001841330\n\nktta:ExercisePriceZeroPointSevenTwoMember\nus-gaap:WarrantMember\n\n2026-01-01\n2026-03-31\n\n0001841330\n\nktta:ExercisePriceZeroPointSevenTwoMember\nus-gaap:WarrantMember\n\n2026-03-31\n\n0001841330\n\nktta:RepresentativeWarrantMember\n\n2026-03-31\n\n0001841330\n\nktta:PublicWarrantMember\n\n2026-03-31\n\n0001841330\n\n2026-03-31\n\n0001841330\n\n2025-12-31\n2025-12-31\n\n0001841330\n\n2025-12-31\n\n0001841330\n\nResearchandDevelopmentExpenseMember\n\n2025-01-01\n2025-03-31\n\n0001841330\n\nGeneralandAdministrativeExpenseMember\n\n2025-01-01\n2025-03-31\n\n0001841330\n\nResearchandDevelopmentExpenseMember\n\n2026-01-01\n2026-03-31\n\n0001841330\n\nGeneralandAdministrativeExpenseMember\n\n2026-01-01\n2026-03-31\n\n0001841330\n\n2025-01-01\n2025-03-31\n\n0001841330\n\nus-gaap:EmployeeStockOptionMember\n\n2025-01-01\n2025-03-31\n\n0001841330\n\nus-gaap:EmployeeStockOptionMember\n\n2026-01-01\n2026-03-31\n\n0001841330\n\nktta:DecemberTwoThousandTwentyFIVEPreFundedWarrantsMember\n\n2026-03-31\n\n0001841330\n\nus-gaap:CommonStockMember\n\n2026-01-01\n2026-03-31\n\n0001841330\n\nus-gaap:CommonStockMember\n\n2026-03-31\n\n0001841330\n\nktta:DecemberTwoThousandTwentyFIVEPreFundedWarrantsMember\n\n2026-01-01\n2026-03-31\n\n0001841330\n\nktta:DecemberTwoThousandTwentyFivePlacementAgentWarrantsMember\n\n2026-01-28\n2026-01-28\n\n0001841330\n\nktta:DecemberTwoThousandTwentyFivePlacementAgentWarrantsMember\n\n2026-01-28\n\n0001841330\n\nsrt:MaximumMember\nus-gaap:CommonStockMember\n\n2026-01-28\n\n0001841330\n\nsrt:MinimumMember\nus-gaap:CommonStockMember\n\n2026-01-28\n\n0001841330\n\nktta:DecemberTwoThousandTwentyFivePlacementAgentWarrantsMember\n\n2025-01-01\n2025-12-31\n\n0001841330\n\nktta:PlacementAgentWarrantsMember\n\n2026-01-01\n2026-03-31\n\n0001841330\n\nus-gaap:CommonStockMember\nktta:DecemberTwoThousandTwentyFivePlacementAgentWarrantsMember\n\n2026-03-31\n\n0001841330\n\nus-gaap:CommonStockMember\nktta:DecemberTwoThousandTwentyFivePublicOfferingMember\n\n2026-03-31\n\n0001841330\n\nktta:DecemberTwoThousandTwentyFivePublicOfferingMember\nktta:PreFundedWarrantsMember\n\n2026-03-31\n\n0001841330\n\nktta:DecemberTwoThousandTwentyFivePublicOfferingMember\n\n2026-03-31\n\n0001841330\n\nktta:DecemberTwoThousandTwentyFIVEPreFundedWarrantsMember\n\n2025-11-28\n\n0001841330\n\nktta:PreFundedWarrantsMember\n\n2025-11-28\n\n0001841330\n\nus-gaap:CommonStockMember\n\n2025-11-28\n2025-11-28\n\n0001841330\n\nktta:May2025PlacementAgentWarrantsMember\n\n2026-03-31\n\n0001841330\n\nktta:SeriesDWarrantsMember\n\n2026-01-01\n2026-03-31\n\n0001841330\n\nktta:OwnershipLimitationMember\nktta:Warrants1Member\n\n2026-03-31\n\n0001841330\n\nktta:PrivateInvestmentInPublicEquityPIPEWarrantsMember\nktta:Warrants1Member\n\n2026-03-31\n\n0001841330\n\nktta:PrivateInvestmentInPublicEquityPIPEWarrantsMember\n\n2026-03-31\n\n0001841330\n\nktta:May2025PreFundedWarrantMember\n\n2026-01-01\n2026-03-31\n\n0001841330\n\nus-gaap:CommonStockMember\nktta:SeriesDWarrantsMember\n\n2026-01-01\n2026-03-31\n\n0001841330\n\nus-gaap:CommonStockMember\nktta:SeriesDWarrantsMember\n\n2026-03-31\n\n0001841330\n\nktta:SeriesDWarrantsMember\n\n2026-03-31\n\n0001841330\n\nktta:SeriesCWarrantsMember\n\n2026-03-31\n\n0001841330\n\nktta:PreFundedWarrantsMember\n\n2026-03-31\n\n0001841330\n\nktta:May2025PreFundedWarrantMember\n\n2026-03-31\n\n0001841330\n\nus-gaap:IPOMember\n\n2026-03-31\n\n0001841330\n\nus-gaap:CommonStockMember\n\n2025-05-06\n\n0001841330\n\nus-gaap:CommonStockMember\nktta:SeriesCWarrantsMember\n\n2026-03-31\n\n0001841330\n\nus-gaap:CommonStockMember\nktta:May2025PreFundedWarrantMember\n\n2025-05-06\n\n0001841330\n\nktta:SecuritiesPurchaseAgreementsMember\nktta:SeriesDWarrantsMember\n\n2026-03-31\n\n0001841330\n\nktta:SecuritiesPurchaseAgreementsMember\n\n2025-05-06\n\n0001841330\n\nktta:SecuritiesPurchaseAgreementsMember\nktta:SeriesCWarrantsMember\n\n2025-05-06\n\n0001841330\n\nktta:SecuritiesPurchaseAgreementsMember\nus-gaap:CommonStockMember\nktta:PreFundedWarrantsMember\n\n2025-05-06\n\n0001841330\n\nktta:SecuritiesPurchaseAgreementsMember\nktta:PreFundedWarrantsMember\n\n2025-05-06\n\n0001841330\n\nktta:SecuritiesPurchaseAgreementsMember\nus-gaap:CommonStockMember\n\n2025-05-06\n\n0001841330\n\nktta:ATMAgreementMember\nus-gaap:CommonStockMember\n\n2025-01-01\n2025-03-31\n\n0001841330\n\nktta:ATMAgreementMember\nus-gaap:CommonStockMember\n\n2025-03-31\n\n0001841330\n\nktta:ATMAgreementMember\nus-gaap:CommonStockMember\n\n2025-06-20\n2025-06-20\n\n0001841330\n\nsrt:MaximumMember\nktta:ATMAgreementMember\nus-gaap:CommonStockMember\n\n2025-06-20\n\n0001841330\n\nsrt:MinimumMember\nktta:ATMAgreementMember\n\n2025-06-20\n\n0001841330\n\nktta:ATMAgreementMember\nus-gaap:CommonStockMember\n\n2024-12-31\n\n0001841330\n\n2024-11-26\n2024-11-26\n\n0001841330\n\nktta:TwoThousandTwentyThreeStockIncentivePlanMember\n\n2026-03-31\n\n0001841330\n\nus-gaap:CommonStockMember\nktta:TwoThousandTwentyThreeStockIncentivePlanMember\n\n2026-03-31\n\n0001841330\n\nsrt:MaximumMember\nus-gaap:CommonStockMember\nktta:TwoThousandTwentyThreeStockIncentivePlanMember\n\n2026-01-28\n\n0001841330\n\nsrt:MinimumMember\nus-gaap:CommonStockMember\nktta:TwoThousandTwentyThreeStockIncentivePlanMember\n\n2026-01-28\n\n0001841330\n\nsrt:MaximumMember\nus-gaap:CommonStockMember\nktta:TwoThousandTwentyThreeStockIncentivePlanMember\n\n2025-09-03\n\n0001841330\n\nsrt:MinimumMember\nus-gaap:CommonStockMember\nktta:TwoThousandTwentyThreeStockIncentivePlanMember\n\n2025-09-03\n\n0001841330\n\nktta:TwoThousandTwentyThreeStockIncentivePlanMember\n\n2026-01-01\n2026-03-31\n\n0001841330\n\nus-gaap:RestrictedStockUnitsRSUMember\nktta:TwoThousandTwentyThreeStockIncentivePlanMember\n\n2026-03-31\n\n0001841330\n\nktta:TwoThousandTwentyOneIncentivePlanMember\n\n2026-03-31\n\n0001841330\n\nus-gaap:PatentsMember\n\n2025-12-31\n\n0001841330\n\nus-gaap:PatentsMember\n\n2026-03-31\n\n0001841330\n\nus-gaap:InProcessResearchAndDevelopmentMember\n\n2025-12-31\n\n0001841330\n\ncurrency:AUD\n\n2025-03-31\n\n0001841330\n\ncurrency:AUD\n\n2026-03-31\n\n0001841330\n\nus-gaap:WarrantMember\n\n2025-01-01\n2025-03-31\n\n0001841330\n\nus-gaap:WarrantMember\n\n2026-01-01\n2026-03-31\n\n0001841330\n\nus-gaap:StockOptionMember\n\n2025-01-01\n2025-03-31\n\n0001841330\n\nus-gaap:StockOptionMember\n\n2026-01-01\n2026-03-31\n\n0001841330\n\nktta:DerivativeWarrantLiabilitiesMember\nus-gaap:FairValueInputsLevel3Member\n\n2026-01-01\n2026-03-31\n\n0001841330\n\nktta:DerivativeWarrantLiabilitiesMember\nus-gaap:FairValueInputsLevel3Member\n\n2025-12-31\n\n0001841330\n\nktta:RepresentativeWarrantLiabilitiesMember\nus-gaap:FairValueInputsLevel3Member\n\n2025-03-31\n\n0001841330\n\nktta:RepresentativeWarrantLiabilitiesMember\nus-gaap:FairValueInputsLevel3Member\n\n2026-03-31\n\n0001841330\n\nktta:RepresentativeWarrantLiabilitiesMember\nus-gaap:FairValueInputsLevel3Member\n\n2025-01-01\n2025-03-31\n\n0001841330\n\nktta:RepresentativeWarrantLiabilitiesMember\nus-gaap:FairValueInputsLevel3Member\n\n2026-01-01\n2026-03-31\n\n0001841330\n\nktta:RepresentativeWarrantLiabilitiesMember\nus-gaap:FairValueInputsLevel3Member\n\n2024-12-31\n\n0001841330\n\nktta:RepresentativeWarrantLiabilitiesMember\nus-gaap:FairValueInputsLevel3Member\n\n2025-12-31\n\n0001841330\n\nus-gaap:FairValueMeasurementsRecurringMember\nktta:RepresentativeWarrantLiabilitiesMember\nus-gaap:FairValueInputsLevel3Member\n\n2025-12-31\n\n0001841330\n\nus-gaap:FairValueMeasurementsRecurringMember\nktta:RepresentativeWarrantLiabilitiesMember\n\n2025-12-31\n\n0001841330\n\nus-gaap:FairValueMeasurementsRecurringMember\nktta:PublicWarrantLiabilitiesMember\nus-gaap:FairValueInputsLevel1Member\n\n2025-12-31\n\n0001841330\n\nus-gaap:FairValueMeasurementsRecurringMember\nktta:PublicWarrantLiabilitiesMember\n\n2025-12-31\n\n0001841330\n\nus-gaap:FairValueMeasurementsRecurringMember\nktta:RepresentativeWarrantLiabilitiesMember\nus-gaap:FairValueInputsLevel3Member\n\n2026-03-31\n\n0001841330\n\nus-gaap:FairValueMeasurementsRecurringMember\nktta:RepresentativeWarrantLiabilitiesMember\n\n2026-03-31\n\n0001841330\n\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel1Member\n\n2025-12-31\n\n0001841330\n\nus-gaap:FairValueMeasurementsRecurringMember\n\n2025-12-31\n\n0001841330\n\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel1Member\n\n2026-03-31\n\n0001841330\n\nus-gaap:FairValueMeasurementsRecurringMember\n\n2026-03-31\n\n0001841330\n\n2025-03-31\n\n0001841330\n\n2024-12-31\n\n0001841330\n\nus-gaap:RetainedEarningsMember\n\n2026-03-31\n\n0001841330\n\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n\n2026-03-31\n\n0001841330\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2026-03-31\n\n0001841330\n\nus-gaap:RetainedEarningsMember\n\n2026-01-01\n2026-03-31\n\n0001841330\n\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n\n2026-01-01\n2026-03-31\n\n0001841330\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2026-01-01\n2026-03-31\n\n0001841330\n\nus-gaap:RetainedEarningsMember\n\n2025-12-31\n\n0001841330\n\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n\n2025-12-31\n\n0001841330\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-12-31\n\n0001841330\n\nus-gaap:CommonStockMember\n\n2025-12-31\n\n0001841330\n\nus-gaap:RetainedEarningsMember\n\n2025-03-31\n\n0001841330\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-03-31\n\n0001841330\n\nus-gaap:CommonStockMember\n\n2025-03-31\n\n0001841330\n\nus-gaap:RetainedEarningsMember\n\n2025-01-01\n2025-03-31\n\n0001841330\n\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n\n2025-01-01\n2025-03-31\n\n0001841330\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-01-01\n2025-03-31\n\n0001841330\n\nus-gaap:CommonStockMember\n\n2025-01-01\n2025-03-31\n\n0001841330\n\nus-gaap:RetainedEarningsMember\n\n2024-12-31\n\n0001841330\n\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n\n2024-12-31\n\n0001841330\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2024-12-31\n\n0001841330\n\nus-gaap:CommonStockMember\n\n2024-12-31\n\n0001841330\n\n2026-05-13\n\n0001841330\n\nktta:WarrantsToPurchaseSharesOfCommonStockParValue00001PerShareMember\n\n2026-01-01\n2026-03-31\n\n0001841330\n\nktta:CommonStockParValue00001PerShareMember\n\n2026-01-01\n2026-03-31\n\n0001841330\n\nsrt:MinimumMember\n\n2026-03-31\n\n0001841330\n\nsrt:MaximumMember\n\n2026-03-31\n\n0001841330\n\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel2Member\n\n2026-03-31\n\n0001841330\n\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel3Member\n\n2026-03-31\n\n0001841330\n\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel2Member\n\n2025-12-31\n\n0001841330\n\nus-gaap:FairValueMeasurementsRecurringMember\nus-gaap:FairValueInputsLevel3Member\n\n2025-12-31\n\n0001841330\n\nus-gaap:FairValueMeasurementsRecurringMember\nktta:PublicWarrantLiabilitiesMember\n\n2026-03-31\n\n0001841330\n\nus-gaap:FairValueMeasurementsRecurringMember\nktta:PublicWarrantLiabilitiesMember\nus-gaap:FairValueInputsLevel1Member\n\n2026-03-31\n\n0001841330\n\nus-gaap:FairValueMeasurementsRecurringMember\nktta:PublicWarrantLiabilitiesMember\nus-gaap:FairValueInputsLevel2Member\n\n2026-03-31\n\n0001841330\n\nus-gaap:FairValueMeasurementsRecurringMember\nktta:PublicWarrantLiabilitiesMember\nus-gaap:FairValueInputsLevel3Member\n\n2026-03-31\n\n0001841330\n\nus-gaap:FairValueMeasurementsRecurringMember\nktta:RepresentativeWarrantLiabilitiesMember\nus-gaap:FairValueInputsLevel1Member\n\n2026-03-31\n\n0001841330\n\nus-gaap:FairValueMeasurementsRecurringMember\nktta:RepresentativeWarrantLiabilitiesMember\nus-gaap:FairValueInputsLevel2Member\n\n2026-03-31\n\n0001841330\n\nus-gaap:FairValueMeasurementsRecurringMember\nktta:PublicWarrantLiabilitiesMember\nus-gaap:FairValueInputsLevel2Member\n\n2025-12-31\n\n0001841330\n\nus-gaap:FairValueMeasurementsRecurringMember\nktta:PublicWarrantLiabilitiesMember\nus-gaap:FairValueInputsLevel3Member\n\n2025-12-31\n\n0001841330\n\nus-gaap:FairValueMeasurementsRecurringMember\nktta:RepresentativeWarrantLiabilitiesMember\nus-gaap:FairValueInputsLevel1Member\n\n2025-12-31\n\n0001841330\n\nus-gaap:FairValueMeasurementsRecurringMember\nktta:RepresentativeWarrantLiabilitiesMember\nus-gaap:FairValueInputsLevel2Member\n\n2025-12-31\n\n0001841330\n\nktta:DerivativeWarrantLiabilitiesMember\nus-gaap:FairValueInputsLevel3Member\n\n2024-12-31\n\n0001841330\n\nktta:DerivativeWarrantLiabilitiesMember\nus-gaap:FairValueInputsLevel3Member\n\n2025-01-01\n2025-03-31\n\n0001841330\n\nktta:DerivativeWarrantLiabilitiesMember\nus-gaap:FairValueInputsLevel3Member\n\n2026-03-31\n\n0001841330\n\nktta:DerivativeWarrantLiabilitiesMember\nus-gaap:FairValueInputsLevel3Member\n\n2025-03-31\n\n0001841330\n\ncurrency:GBP\n\n2026-03-31\n\n0001841330\n\ncurrency:GBP\n\n2025-03-31\n\n0001841330\n\ncurrency:EUR\n\n2026-03-31\n\n0001841330\n\ncurrency:EUR\n\n2025-03-31\n\n0001841330\n\nus-gaap:AccumulatedOtherComprehensiveIncomeMember\n\n2025-03-31\n\n0001841330\n\nus-gaap:InProcessResearchAndDevelopmentMember\n\n2026-03-31\n\n0001841330\n\nktta:ATMAgreementMember\nus-gaap:CommonStockMember\n\n2026-01-01\n2026-03-31\n\nxbrli:shares\n\niso4217:USD\n\niso4217:USD\n\nxbrli:shares\n\nxbrli:pure\n\nktta:segment\n\n \n\n \n\nUNITED STATES\n\nSECURITIES AND EXCHANGE COMMISSION\n\nWASHINGTON, D.C. 20549\n\n \n\nFORM 10-Q\n\n \n\n☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934\n\n \n\nFor the Quarterly Period Ended March 31, 2026\n\n \n\nOR\n\n \n\n☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934\n\n \n\nFor the transition period from ________ to\n________.\n\n \n\nCommission file number: 001-40804\n\n \n\nPASITHEA THERAPEUTICS CORP.\n\n(Exact name of Registrant as specified in its\ncharter)\n\n \n\nDelaware 85-1591963\n\n(State or other jurisdiction of\n\nincorporation or organization)\n \n(I.R.S. Employer\n\nIdentification No.)\n\n \n\n1111 Lincoln Road, Suite 500\nMiami Beach, Florida 33139\n\n(Address of principal executive offices)\n \n(Zip Code)\n\n \n\n(786) 977-3380\n\n(Registrant’s telephone number, including\narea code)\n\n \n\nN/A\n(Former name, former address and former fiscal year, if changed since last report)\n\n \n\nSecurities registered pursuant to Section 12(b) of the Act:\n\n \n\nTitle of each class\n \nTrading Symbol(s)\n \nName of each exchange on which registered\n\nCommon Stock, par value $0.0001 per share KTTA The Nasdaq Capital Market\n\nWarrants, to purchase shares of Common Stock, par value $0.0001 per share KTTAW The Nasdaq Capital Market\n\n \n\nIndicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No\n\n \n\nIndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No\n\n \n\nIndicate by check mark whether the registrant is a large accelerated\nfiler, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions\nof “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging\ngrowth company” in Rule 12b-2 of the Exchange Act.\n\n \n\nLarge Accelerated Filer\n☐\nAccelerated Filer\n☐\n\nNon-Accelerated Filer☒Smaller Reporting Company☒\n\n  Emerging Growth Company☒\n\n \n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐\n\n \n\nIndicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No\n\n \n\nAs of May 13, 2026, there were 33,414,448 shares of the registrant’s common stock outstanding. This number does not include 54,828,835 shares of common stock issuable upon the exercise of pre-funded warrants outstanding as of May 13, 2026 (which are immediately exercisable at an exercise price of $0.001 per share of common stock, subject to beneficial ownership limitations).\n\n \n\n \n\n \n\n \n\n \n\n \n\nPASITHEA THERAPEUTICS CORP.\n\nFORM 10-Q\n\nFor the Quarter ended March 31, 2026\n\n \n\n \nPage\n\n \n \n\n[PART I. FINANCIAL INFORMATION](#a_001)"}